Background/goals:Â Colon most cancers stays a life-threating illness with rising morbidity and mortality worldwide regardless of the development in trendy medical remedy. Subsequently, novel and efficient anti-colon cancers medicine are urgently wanted. On this research, we investigated the anti-metastatic property EnDuo, a modified model of Endostar, and the underlying mechanisms.
Strategies: Colon most cancers cells had been handled with completely different concentrations of EnDuo (50 μg/mL, 100 μg/mL, 200 μg/mL), and Endostar (100 μg/mL) as optimistic management. Cell Counting Equipment-Eight assay was carried out to check the impact of EnDuo on cell viability. A scratch wound assay and transwell assay had been employed to judge the relocation and motility of malignant colon cells following remedy with EnDuo. Western blot evaluation was used to find out inhibitory results of EnDuo by detecting the phosphorylation degree of AKT and ERK proteins, and the expression of MMP-2 and MMP-9 proteins.
Outcomes:Â Our outcomes confirmed that EnDuo impedes the migration of colon most cancers cells in a dose-dependent method. On the molecular degree, EnDuo induced a major discount within the phosphorylation of AKT and ERK proteins, and inhibited the expression of MMP-2 and MMP-9 proteins.
Conclusions:Â Collectively, these outcomes display that EnDuo reveals a comparable anti-metastatic impact by suppressing the migration of colon most cancers cells. Presumably, EnDuo interrupts the PI3K/AKT/ERK signaling pathway to arrest cell migration. Our research supplies a novel perception to the potential medical functions of EnDuo towards colon cancers sooner or later.
Analysis of COVID-19 for controlling the pandemic: A overview of the state-of-the-art
Up to now, well being organizations and nations all over the world are struggling to fully management the unfold of the coronavirus illness 2019 (COVID-19). Scientists and researchers are growing assessments for the speedy detection of people who might carry the extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whereas striving to discover a appropriate vaccine to immunize wholesome people. As there are clinically reported circumstances of asymptomatic carriers of SARS-CoV-2, quick and correct analysis performs an necessary position within the management and additional prevention of this illness. Herein, we current current applied sciences and strategies which have been carried out for the analysis of COVID-19.
We summarize the strategies created by completely different analysis institutes in addition to the business units and kits developed by corporations for the detection of SARS-CoV-2. The outline of the present strategies is adopted by highlighting their benefits and challenges. Lastly, we suggest some promising strategies that might probably be utilized to the detection of SARS-CoV-2, and tracing the asymptomatic carriers of COVID-19 quickly and precisely within the early levels of an infection, primarily based on reviewing the analysis research on the detection of comparable infectious viruses, particularly extreme acute respiratory syndrome (SARS) coronavirus, and Center East respiratory syndrome (MERS) coronavirus. Maglumi and iFlash had the very best analytical sensitivity for IgM and IgG, respectively. Axceed kits had a linearity response within the detected focus.
The medical sensitivity of Axceed, iFlash, and Maglumi was 68.0%, 64.9%, and 63.9% with a specificity of 99.0%, 96.0%, and 100% for IgM, 85.6%, 97.9%, and 94.8% with a specificity of 97.0% for IgG. ROC evaluation indicated all kits had a diagnostic energy larger than 0.9. Notably, both IgM or IgG kits obtained a poor settlement (Kappa worth from 0.397 to 0.713) with others. Amongst 38 recovered sufferers, 94.7% had an efficient immune response, and each seropositive IgM and IgG accounted for the most important proportion (medium, 42 days onset), then adopted by the only seropositive IgG (medium, 50 days onset) in Ab profile.
EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation
MicroRNA-198 inhibits metastasis of thyroid most cancers by focusing on H3F3A
Goal:Â This research was designed to research the position of microRNA-198 in thyroid most cancers (TCa) development.
Sufferers and strategies: Quantitative real-time polymerase chain response (qRT-PCR) was carried out to look at microRNA-198 and H3F3A ranges in tumor tissue specimens and paracancerous ones collected from 50 sufferers with TCa, and the interaction between microRNA-198 or H3F3A and a few medical indicators or prognosis of TCa sufferers was analyzed as effectively. MicroRNA-198 and H3F3A overexpression fashions had been constructed utilizing lentivirus in TCa cell strains TPC-1 and BHP2-7, and the impacts of microRNA-198 on TCa cell features had been evaluated by utilizing cell counting equipment-8 (CCK-8), plate clone formation, and transwell assays. Lastly, restoration investigations had been carried out to discover the underlying mechanisms in addition to the interplay between microRNA-198 and H3F3A.
Outcomes:Â QRT-PCR indicated that in tumor tissues of TCa sufferers, microRNA-198 confirmed a remarkably decrease expression than in adjoining regular tissue samples. In contrast with sufferers with excessive expression of microRNA-198, these with microRNA-198 low expression had extra superior tumor stage, bigger tumor measurement, increased lymph node metastasis price, and decrease general survival price. In the meantime, the outcomes of analysis on H3F3A had been simply reverse to the above observations on microRNA-198. In in vitro cell experiments, overexpression of microRNA-198 considerably weakened the proliferation and migration means of thyroid tumor cells.
 Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K2201-400 |
ApexBio |
400 assays |
EUR 1503.6 |
Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K129-400 |
Biovision |
each |
EUR 1246.8 |
 Annexin V-PE Apoptosis Kit Plus |
|
K2059-400 |
ApexBio |
400 assays |
EUR 1270.8 |
Annexin V-PE Apoptosis Kit Plus |
|
K203-400 |
Biovision |
each |
EUR 1136.4 |
) Annexin V Apoptosis Detection Kit (PE) |
|
55R-1288 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
Annexin V Apoptosis Detection Kit (PE) |
|
abx290003-100test |
Abbexa |
100 test |
EUR 693.6 |
|
|
Annexin V Apoptosis Detection Kit (PE) |
|
abx290015-200test |
Abbexa |
200 test |
EUR 644.4 |
|
|
 Annexin V-PE Apoptosis Detection Kit |
|
K2200-100 |
ApexBio |
100 assays |
EUR 619.2 |
Annexin V-PE Apoptosis Detection Kit |
|
K2200-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-PE Apoptosis Detection Kit |
|
K128-100 |
Biovision |
each |
EUR 601.2 |
Annexin V-PE Apoptosis Detection Kit |
|
K128-25 |
Biovision |
each |
EUR 248.4 |
 mPEG-CH3?400 |
|
33-MF001049-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 (CY5)) Annexin V Apoptosis Detection Kit (PE) (CY5) |
|
55R-1289 |
Fitzgerald |
25 assays |
EUR 416.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V Apoptosis Detection Kit Plus (PE) |
|
55R-1304 |
Fitzgerald |
25 assays |
EUR 363.6 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V / 7AAD Apoptosis Detection Kit (PE) |
|
abx290009-100test |
Abbexa |
100 test |
EUR 594 |
|
|
) Annexin V Apoptosis Detection Kit : PE (OKTA00005) |
|
OKTA00005 |
Aviva Systems Biology |
KIT |
EUR 364.8 |
|
Description: Description of target: ;Species reactivity: ;Application: FC;Assay info: ;Sensitivity: |
Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K2201-100 |
ApexBio |
100 assays |
EUR 668.4 |
Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K2201-25 |
ApexBio |
25 assays |
EUR 351.6 |
Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K129-100 |
Biovision |
each |
EUR 588 |
Annexin V-PE-Cy5 Apoptosis Detection Kit |
|
K129-25 |
Biovision |
each |
EUR 301.2 |
 HO-PEG-COOH,400 |
|
33-HE002017-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SH-PEG-COOH,400 |
|
33-HE003017-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 HS-PEG-NHS,400 |
|
33-HE003023-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SH-PEG-Biotin,400 |
|
33-HE003041-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 NH2-PEG-COOH,400 |
|
33-HE005017-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SH-PEG-SH,400 |
|
33-HO003003-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 COOH-PEG-COOH,400 |
|
33-HO017017-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,400 |
|
33-HO023023-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 Annexin V-FITC Apoptosis Kit |
|
K2003-400 |
ApexBio |
400 assays |
EUR 1336.8 |
 Annexin V-Cy3 Apoptosis Kit |
|
K2004-400 |
ApexBio |
400 assays |
EUR 1336.8 |
 Annexin V-Cy5 Apoptosis Kit |
|
K2005-400 |
ApexBio |
400 assays |
EUR 1336.8 |
 Annexin V-EGFP Apoptosis Kit |
|
K2006-400 |
ApexBio |
400 assays |
EUR 1336.8 |
 Annexin V-Biotin Apoptosis Kit |
|
K2009-400 |
ApexBio |
400 assays |
EUR 1336.8 |
Annexin V-FITC Apoptosis Kit |
|
K101-400 |
Biovision |
each |
EUR 1227.6 |
Annexin V-Cy3 Apoptosis Kit |
|
K102-400 |
Biovision |
each |
EUR 1149.6 |
Annexin V-Cy5 Apoptosis Kit |
|
K103-400 |
Biovision |
each |
EUR 1227.6 |
Annexin V-EGFP Apoptosis Kit |
|
K104-400 |
Biovision |
each |
EUR 1149.6 |
Annexin V-Biotin Apoptosis Kit |
|
K109-400 |
Biovision |
each |
EUR 1149.6 |
 SH-PEG-NH-Methoxyphenone,400 |
|
33-HE003071-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 / 7-AAD Apoptosis Detection Kit (PE)) Annexin V (PE) / 7-AAD Apoptosis Detection Kit (PE) |
|
abx090609-100tests |
Abbexa |
100 tests |
EUR 718.8 |
|
|
 Annexin V-PE/7-AAD Apoptosis Detection Kit |
|
A213-01 |
Vazyme |
50 rxn |
EUR 286.8 |
Annexin V-PE/7-AAD Apoptosis Detection Kit |
|
A213-02 |
Vazyme |
100 rxn |
EUR 369.6 |
 Annexin V-FITC Apoptosis Kit Plus |
|
K2057-400 |
ApexBio |
400 assays |
EUR 1270.8 |
 Annexin V-Cy3 Apoptosis Kit Plus |
|
K2058-400 |
ApexBio |
400 assays |
EUR 1270.8 |
Annexin V-FITC Apoptosis Kit Plus |
|
K201-400 |
Biovision |
each |
EUR 1136.4 |
Annexin V-Cy3 Apoptosis Kit Plus |
|
K202-400 |
Biovision |
each |
EUR 1136.4 |
) Annexin V Apoptosis Detection Kit (FITC) |
|
55R-1265 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V Apoptosis Detection Kit (CY3) |
|
55R-1266 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V Apoptosis Detection Kit (CY5) |
|
55R-1267 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
 Annexin V EGFP Apoptosis Detection Kit |
|
55R-1268 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V Apoptosis Detection Kit (biotin) |
|
55R-1271 |
Fitzgerald |
25 assays |
EUR 332.4 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
Annexin V Apoptosis Detection Kit (FITC) |
|
abx290002-100test |
Abbexa |
100 test |
EUR 644.4 |
|
|
Annexin V Apoptosis Detection Kit (FITC) |
|
abx290014-200test |
Abbexa |
200 test |
EUR 577.2 |
|
|
) Annexin V Apoptosis Detection Kit (Biotin) |
|
abx290017-200test |
Abbexa |
200 test |
EUR 744 |
|
|
) Annexin V Apoptosis Detection Kit Plus (FITC) |
|
55R-1302 |
Fitzgerald |
25 assays |
EUR 355.2 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
) Annexin V Apoptosis Detection Kit Plus (CY3) |
|
55R-1303 |
Fitzgerald |
25 assays |
EUR 355.2 |
|
Description: Annexin V Apoptosis Kit for detection of apoptosis in the research laboratory |
 Annexin V-FITC/PI Apoptosis Detection Kit |
|
A211-01 |
Vazyme |
50 rxn |
EUR 259.2 |
Annexin V-FITC/PI Apoptosis Detection Kit |
|
A211-02 |
Vazyme |
100 rxn |
EUR 354 |
 / PI Apoptosis Detection Kit) Annexin V (FITC) / PI Apoptosis Detection Kit |
|
abx090601-100tests |
Abbexa |
100 tests |
EUR 552 |
|
|
) Annexin V / PI Apoptosis Detection Kit (FITC) |
|
abx290007-100test |
Abbexa |
100 test |
EUR 543.6 |
|
|
) Annexin V / 7ADD Apoptosis Detection Kit (FITC) |
|
abx290008-100test |
Abbexa |
100 test |
EUR 543.6 |
|
|
) Annexin V / PI Apoptosis Detection Kit (Biotin) |
|
abx290011-100test |
Abbexa |
100 test |
EUR 744 |
|
|
) Annexin V Apoptosis Detection Kit (Dylight 634) |
|
abx290016-200test |
Abbexa |
200 test |
EUR 644.4 |
|
|
) Annexin V Apoptosis Detection Kit (CF-Blue) |
|
abx290018-200test |
Abbexa |
200 test |
EUR 744 |
|
|
) Annexin V Apoptosis Detection Kit : APC (OKTA00002) |
|
OKTA00002 |
Aviva Systems Biology |
KIT |
EUR 396 |
|
Description: Description of target: ;Species reactivity: ;Application: ;Assay info: ;Sensitivity: |
) Annexin V Apoptosis Detection Kit : FITC (OKTA00003) |
|
OKTA00003 |
Aviva Systems Biology |
KIT |
EUR 380.4 |
|
Description: Description of target: ;Species reactivity: ;Application: ;Assay info: ;Sensitivity: |
Annexin V-PE Apoptosis Kit Plus |
|
K2059-100 |
ApexBio |
100 assays |
EUR 619.2 |
Annexin V-PE Apoptosis Kit Plus |
|
K2059-25 |
ApexBio |
25 assays |
EUR 301.2 |
Annexin V-PE Apoptosis Kit Plus |
|
K203-100 |
Biovision |
each |
EUR 582 |
Annexin V-PE Apoptosis Kit Plus |
|
K203-25 |
Biovision |
each |
EUR 280.8 |
 / 7-AAD Apoptosis Detection Kit) Annexin V (FITC) / 7-AAD Apoptosis Detection Kit |
|
abx090603-100tests |
Abbexa |
100 tests |
EUR 594 |
|
|
 / PI Apoptosis Detection Kit (APC)) Annexin V (APC) / PI Apoptosis Detection Kit (APC) |
|
abx090605-100tests |
Abbexa |
100 tests |
EUR 777.6 |
|
|
 Annexin V-FITC / PI Cell Apoptosis Detection Kit |
|
20-abx098246 |
Abbexa |
|
|
|
|
 Annexin V-EGFP / PI Cell Apoptosis Detection Kit |
|
20-abx098247 |
Abbexa |
|
|
|
|
) Annexin V / PI Apoptosis Detection Kit (Dylight 634) |
|
abx290010-100test |
Abbexa |
100 test |
EUR 644.4 |
|
|
) Annexin V / PI Apoptosis Detection Kit (CF-Blue) |
|
abx290012-100test |
Abbexa |
100 test |
EUR 678 |
|
|
) Annexin V / 7AAD Apoptosis Detection Kit (CF-Blue) |
|
abx290013-100test |
Abbexa |
100 test |
EUR 678 |
|
|
) Aposcreen Annexin V Apoptosis Kit : PE (OKSB00008) |
|
OKSB00008 |
Aviva Systems Biology |
100 Tests |
EUR 615.6 |
|
Description: Description of target: ;Species reactivity: ;Application: FC;Assay info: The ApoScreen Annexin V Apoptosis Kit employs a fluorescein- labeled annexin V (annexin V- FITC) in concert withpropidium iodide (PI) to evaluate subpopulations of cells undergoing apoptosis. During the early stages of apoptosis,cells begin to display PS on the outer cell membrane where it is readily detectable by staining the cells with annexin VFITC.As the plasma membrane becomes increasingly permeable during the later stages of apoptosis, PI can readilymove across the cell membrane and bind to cellular DNA, providing a means for identifying those cells that have lostmembrane integrity through mechanisms including necrosis. When cells are double stained with annexin V- FITC and PI,three different cell populations may be observed (Figure 2): (i) live cells that do not stain with either annexin V- FITC or PI;(ii) necrotic cells that stain with both reagents; and (iii) apoptotic cells that stain with annexin V- FITC only. Analysis canbe performed on any flow cytometer equipped with a single laser using excitation at 488 nm. Alternatively, the cells canbe examined with a fluorescence microscope equipped with filters for discrimination of FITC and rhodamine/PI.;Sensitivity: |
 / 7-AAD Apoptosis Detection Kit (APC)) Annexin V (APC) / 7-AAD Apoptosis Detection Kit (APC) |
|
abx090607-100tests |
Abbexa |
100 tests |
EUR 811.2 |
|
|
Annexin V-FITC Apoptosis Kit |
|
K2003-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-Cy3 Apoptosis Kit |
|
K2004-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-Cy5 Apoptosis Kit |
|
K2005-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-EGFP Apoptosis Kit |
|
K2006-100 |
ApexBio |
100 assays |
EUR 619.2 |
Annexin V-EGFP Apoptosis Kit |
|
K2006-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-Biotin Apoptosis Kit |
|
K2009-25 |
ApexBio |
25 assays |
EUR 285.6 |
Annexin V-FITC Apoptosis Kit |
|
K101-100 |
Biovision |
each |
EUR 614.4 |
Annexin V-FITC Apoptosis Kit |
|
K101-25 |
Biovision |
each |
EUR 268.8 |
Annexin V-Cy3 Apoptosis Kit |
|
K102-100 |
Biovision |
each |
EUR 601.2 |
Annexin V-Cy3 Apoptosis Kit |
|
K102-25 |
Biovision |
each |
EUR 248.4 |
Annexin V-Cy5 Apoptosis Kit |
|
K103-100 |
Biovision |
each |
EUR 614.4 |
Annexin V-Cy5 Apoptosis Kit |
|
K103-25 |
Biovision |
each |
EUR 261.6 |
Annexin V-EGFP Apoptosis Kit |
|
K104-100 |
Biovision |
each |
EUR 601.2 |
Annexin V-EGFP Apoptosis Kit |
|
K104-25 |
Biovision |
each |
EUR 248.4 |
Annexin V-Biotin Apoptosis Kit |
|
K109-100 |
Biovision |
each |
EUR 561.6 |
Annexin V-Biotin Apoptosis Kit |
|
K109-25 |
Biovision |
each |
EUR 248.4 |
) Annexin V (PE) |
|
abx090613-100tests |
Abbexa |
100 tests |
EUR 644.4 |
|
|
 Annexin V PE |
|
EXB0027 |
ExBio |
100 tests |
EUR 244.8 |
 DSPE-PEG-NH2 |
|
33-LP096005-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 HO-PEG-NH2,400 |
|
33-HE002005-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SH-PEG-NH2,400 |
|
33-HE003005-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 MAL-PEG-NH2,400 |
|
33-HE022005-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 NH2-PEG-NH2,400 |
|
33-HO005005-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 MitoStep + Apoptosis Detection PE |
|
KMAPE-100T |
ImmunoStep |
100 test |
EUR 551.4 |
Annexin V-FITC Apoptosis Kit Plus |
|
K2057-100 |
ApexBio |
100 assays |
EUR 619.2 |
Annexin V-FITC Apoptosis Kit Plus |
|
K2057-25 |
ApexBio |
25 assays |
EUR 301.2 |
Annexin V-Cy3 Apoptosis Kit Plus |
|
K2058-100 |
ApexBio |
100 assays |
EUR 619.2 |
Annexin V-Cy3 Apoptosis Kit Plus |
|
K2058-25 |
ApexBio |
25 assays |
EUR 301.2 |
Annexin V-FITC Apoptosis Kit Plus |
|
K201-100 |
Biovision |
each |
EUR 601.2 |
Annexin V-FITC Apoptosis Kit Plus |
|
K201-25 |
Biovision |
each |
EUR 288 |
Annexin V-Cy3 Apoptosis Kit Plus |
|
K202-100 |
Biovision |
each |
EUR 588 |
Annexin V-Cy3 Apoptosis Kit Plus |
|
K202-25 |
Biovision |
each |
EUR 288 |
 Annexin V-PE Reagent |
|
1014-1000 |
Biovision |
each |
EUR 1358.4 |
Annexin V-PE Reagent |
|
1014-200 |
Biovision |
each |
EUR 483.6 |
) Annexin V, R-phycoerythrin conjugate (100 assays) |
|
9-29045 |
Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uL |
) Annexin V, Allophycocyanin crosslinked conjugate (100 assays) |
|
9-29057 |
Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uL |
) Aposcreen Annexin V Apoptosis Kit : FITC (OKSB00007) |
|
OKSB00007 |
Aviva Systems Biology |
100 Tests |
EUR 615.6 |
|
Description: Description of target: ;Species reactivity: ;Application: FC, ICC;Assay info: ;Sensitivity: |
 Monoclonal Antibody (Human), PE) Annexin A4 (ANXA4) Monoclonal Antibody (Human), PE |
|
4-MAE784Hu22-PE |
Cloud-Clone |
-
EUR 367.20
-
EUR 3340.80
-
EUR 943.20
-
EUR 463.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Monoclonal Antibody (Pig), PE) Annexin A4 (ANXA4) Monoclonal Antibody (Pig), PE |
|
4-MAE784Po21-PE |
Cloud-Clone |
-
EUR 409.20
-
EUR 3945.60
-
EUR 1094.40
-
EUR 523.20
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Pig Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Monoclonal Antibody (Rat), PE) Annexin A4 (ANXA4) Monoclonal Antibody (Rat), PE |
|
4-MAE784Ra21-PE |
Cloud-Clone |
-
EUR 385.20
-
EUR 3600.00
-
EUR 1008.00
-
EUR 489.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Rat Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Monoclonal Antibody (Human), PE) Annexin A3 (ANXA3) Monoclonal Antibody (Human), PE |
|
4-MAE786Hu21-PE |
Cloud-Clone |
-
EUR 367.20
-
EUR 3340.80
-
EUR 943.20
-
EUR 463.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Annexin A3 (ANXA3). This antibody is labeled with PE. |
Annexin A3 (ANXA3) Monoclonal Antibody (Human), PE |
|
4-MAE786Hu23-PE |
Cloud-Clone |
-
EUR 373.20
-
EUR 3427.20
-
EUR 964.80
-
EUR 471.60
-
EUR 242.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Annexin A3 (ANXA3). This antibody is labeled with PE. |
 Monoclonal Antibody (Dog), PE) Annexin A1 (ANXA1) Monoclonal Antibody (Dog), PE |
|
4-MAE787Ca21-PE |
Cloud-Clone |
-
EUR 397.20
-
EUR 3772.80
-
EUR 1051.20
-
EUR 506.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Dog Annexin A1 (ANXA1). This antibody is labeled with PE. |
 Monoclonal Antibody (Rat), PE) Annexin A1 (ANXA1) Monoclonal Antibody (Rat), PE |
|
4-MAE787Ra21-PE |
Cloud-Clone |
-
EUR 385.20
-
EUR 3600.00
-
EUR 1008.00
-
EUR 489.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Rat Annexin A1 (ANXA1). This antibody is labeled with PE. |
 Monoclonal Antibody (Human), PE) Annexin A5 (ANXA5) Monoclonal Antibody (Human), PE |
|
4-MAA259Hu22-PE |
Cloud-Clone |
-
EUR 346.80
-
EUR 3046.80
-
EUR 868.80
-
EUR 433.20
-
EUR 230.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Annexin A5 (ANXA5). This antibody is labeled with PE. |
 Polyclonal Antibody (Mouse), PE) Annexin A5 (ANXA5) Polyclonal Antibody (Mouse), PE |
|
4-PAA259Mu01-PE |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Annexin A5 (ANXA5). This antibody is labeled with PE. |
 Polyclonal Antibody (Rat), PE) Annexin A5 (ANXA5) Polyclonal Antibody (Rat), PE |
|
4-PAA259Ra01-PE |
Cloud-Clone |
-
EUR 350.40
-
EUR 3098.40
-
EUR 882.00
-
EUR 439.20
-
EUR 232.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Annexin A5 (ANXA5). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), PE) Annexin A9 (ANXA9) Polyclonal Antibody (Human), PE |
|
4-PAE779Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Annexin A9 (ANXA9). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), PE) Annexin A10 (ANXA10) Polyclonal Antibody (Human), PE |
|
4-PAE780Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Annexin A10 (ANXA10). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), PE) Annexin A13 (ANXA13) Polyclonal Antibody (Human), PE |
|
4-PAE783Hu01-PE |
Cloud-Clone |
-
EUR 350.40
-
EUR 3090.00
-
EUR 879.60
-
EUR 438.00
-
EUR 231.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Annexin A13 (ANXA13). This antibody is labeled with PE. |
 Polyclonal Antibody (Bovine), PE) Annexin A4 (ANXA4) Polyclonal Antibody (Bovine), PE |
|
4-PAE784Bo01-PE |
Cloud-Clone |
-
EUR 397.20
-
EUR 3772.80
-
EUR 1051.20
-
EUR 506.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Bovine Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), PE) Annexin A4 (ANXA4) Polyclonal Antibody (Human), PE |
|
4-PAE784Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Polyclonal Antibody (Mouse), PE) Annexin A4 (ANXA4) Polyclonal Antibody (Mouse), PE |
|
4-PAE784Mu01-PE |
Cloud-Clone |
-
EUR 361.20
-
EUR 3254.40
-
EUR 921.60
-
EUR 454.80
-
EUR 236.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Annexin A4 (ANXA4). This antibody is labeled with PE. |
 Polyclonal Antibody (Pig), PE) Annexin A4 (ANXA4) Polyclonal Antibody (Pig), PE |
|
4-PAE784Po01-PE |
Cloud-Clone |
-
EUR 397.20
-
EUR 3772.80
-
EUR 1051.20
-
EUR 506.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Pig Annexin A4 (ANXA4). This antibody is labeled with PE. |
Apart from, Luciferase reporter gene experiment revealed that H3F3A was a selected goal gene for microRNA-198. Furthermore, qRT-PCR indicated that H3F3A and microRNA-198 had been negatively correlated in thyroid carcinoma tissues. As well as, in contrast with NC group, overexpression of H3F3A markedly enhanced the migration and proliferative capability of TCa cells. Lastly, restoration experiment revealed a mutual regulation between microRNA-198 and H3F3A, the 2 of which can collectively take part within the malignant development of TCa.
